Abstract
The RhoA GTPase is crucial in numerous biological functions and is linked to cancer metastasis. However, the understanding of the molecular mechanism responsible for RhoA transcription is still very limited. Here we show that RhoA transcription is orchestrated by the Myc–Skp2–Miz1–p300 transcriptional complex. Skp2 cooperates with Myc to induce RhoA transcription by recruiting Miz1 and p300 to the RhoA promoter independently of Skp1-Cullin-F-box protein containing complex (SCF)–Skp2 E3 ligase activity. Deficiency of this complex results in impairment in RhoA expression, cell migration, invasion, and breast cancer metastasis, recapitulating the phenotypes observed in RhoA knockdown, and RhoA restoration rescues the defect in cell invasion. Overexpression of the Myc–Skp2–Miz1 complex is found in metastatic human cancers and is correlated with RhoA expression. Our study provides insight into how oncogenic Skp2 and Myc coordinate to induce RhoA transcription and establishes a novel SCF–Skp2 E3-ligase-independent function for oncogenic Skp2 in transcription and cancer metastasis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chiang, A. C. & Massagué, J. Molecular basis of metastasis. N. Engl. J. Med. 359, 2814–2823 (2008).
Yang, J. & Weinberg, R. A. Epithelial–mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818–829 (2008).
Jaffe, A. B. & Hall, A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247–269 (2005).
Lahoz, A. & Hall, A. DLC1: a significant GAP in the cancer genome. Genes Dev. 22, 1724–1730 (2008).
Moscow, J. A. et al. Examination of human tumors for rhoA mutations. Oncogene 9, 189–194 (1994).
Rihet, S. et al. Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors. J Cancer Res. Clin. Oncol. 127, 733–738 (2001).
Bellizzi, A. et al. RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Int. J. Mol. Med. 22, 25–31 (2008).
Faried, A., Faried, L. S., Usman, N., Kato, H. & Kuwano, H. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann. Surg. Oncol. 14, 3593–3601 (2007).
Horiuchi, A. et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest. 83, 861–870 (2003).
Zhao, X. et al. Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res. 69, 483–491 (2009).
Pille, J. Y. et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol. Ther. 11, 267–274 (2005).
Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032–1046 (2009).
Kamai, T. et al. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. Br. J. Urol. Int. 91, 234–238 (2003).
Faried, A. et al. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma. Eur. J. Surg. Oncol. 31, 410–414 (2005).
Kleine-Kohlbrecher, D., Adhikary, S. & Eilers, M. Mechanisms of transcriptional repression by Myc. Curr. Top. Microbiol. Immunol. 302, 51–62 (2006).
Adhikary, S. & Eilers, M. Transcriptional regulation and transformation by Myc proteins. Nature Rev. Mol. Cell Biol. 6, 635–645 (2005).
Eilers, M. & Eisenman, R. N. Myc's broad reach. Genes Dev. 22, 2755–2766 (2008).
Adhikary, S. et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123, 409–421 (2005).
Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E. & Tansey, W. P. Skp2 regulates Myc protein stability and activity. Mol. Cell 11, 1177–1188 (2003).
von der Lehr, N. et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol. Cell 11, 1189–1200 (2003).
Ansieau, S. et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79–89 (2008).
Smit, M. A. & Peeper, D. S. Deregulating EMT and senescence: double impact by a single twist. Cancer Cell 14, 5–7 (2008).
Meyer, N. & Penn, L. Z. Reflecting on 25 years with MYC. Nature Rev. Cancer 8, 976–990 (2008).
Prochownik, E. V. c-Myc: linking transformation and genomic instability. Curr. Mol. Med. 8, 446–458 (2008).
Ricci, M. S. et al. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol. Cell. Biol. 24, 8541–8555 (2004).
Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S. & Amati, B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15, 2069–2082 (2001).
Bello-Fernandez, C., Packham, G. & Cleveland, J. L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl Acad. Sci. USA 90, 7804–7808 (1993).
Kaiser, P., Flick, K., Wittenberg, C. & Reed, S. I. Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCFMet30-mediated inactivation of the transcription factor Met4. Cell 102, 303–314 (2000).
Bres, V. et al. A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nature Cell Biol. 5, 754–761 (2003).
Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nature Rev. Cancer 8, 438–449 (2008).
Nakayama, K. I. & Nakayama, K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16, 323–333 (2005).
Liu, Y. et al. The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Mol. Cell. Biol. 26, 3114–3123 (2006).
Stanbrough, M. et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res. 66, 2815–2825 (2006).
Lin, H. K. et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nature Cell Biol. 11, 420–432 (2009).
Kitagawa, M., Lee, S. H. & McCormick, F. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol. Cell 29, 217–231 (2008).
Seoane, J. et al. TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nature Cell Biol. 3, 400–408 (2001).
Staller, P. et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392–399 (2001).
Wanzel, M. et al. A ribosomal protein L23-nucleophosmin circuit coordinates Miz1 function with cell growth. Nature Cell Biol. 10, 1051–1061 (2008).
Wu, S. et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22, 351–360 (2003).
Gupta, G. P. et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446, 765–770 (2007).
Wu, Y. et al. Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416–428 (2009).
Gupta, G. P. et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc. Natl Acad. Sci. USA 104, 19506–19511 (2007).
Wanzel, M., Herold, S. & Eilers, M. Transcriptional repression by Myc. Trends Cell Biol. 13, 146–150 (2003).
Yang, W. L. et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134–1138 (2009).
Acknowledgements
We thank R. Weinberg, W. Sellers, D. Bohmann, W. Tansey, J. M. Sedivy, W. Wei, M. Pagano, M. Eilers, W. S. El-Deiry, L. Yao and D. Sarbassov for reagents. We also thank D. Sarbassov, M. H. Lee and M. G. Lee for comments and suggestions. Special thanks are extended to S. Patterson for editing and critical reading of the manuscript. This work was supported by Research Trust Scholar funds from the M. D. Anderson Cancer Center, the National Cancer Institute's Prostate Cancer Specialized Program of Research Excellence (SPORE) at the M.D. Anderson Cancer Center, a Department of Defense Prostate Cancer New Investigator Award (to H.K.L.) and a grant from the Department of Health, Taiwan (to C.F.L.).
Author information
Authors and Affiliations
Contributions
C.H.C. and H.K.L. designed the experiments and wrote the manuscript. C.H.C., H.K.L., S.W.L., J.W., W.L.Y., C.Y.W. and J.W. performed the experiments. H.Y.K., C.F.L. and H.Y.H. performed the immunochemistry and analysed the data. M.C.H. and P.P.P. provided the cell lines and reagents. K.I.N. provided the Skp2−/− mice.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 2977 kb)
Rights and permissions
About this article
Cite this article
Chan, CH., Lee, SW., Li, CF. et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 12, 457–467 (2010). https://doi.org/10.1038/ncb2047
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2047
This article is cited by
-
Akt: a key transducer in cancer
Journal of Biomedical Science (2022)
-
Disruption of male fertility-critical Dcaf17 dysregulates mouse testis transcriptome
Scientific Reports (2022)
-
The DNA-helicase HELLS drives ALK− ALCL proliferation by the transcriptional control of a cytokinesis-related program
Cell Death & Disease (2021)
-
Skp2 modulates proliferation, senescence and tumorigenesis of glioma
Cancer Cell International (2020)
-
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma
Molecular Cancer (2019)